Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Hepcidin in hepatocellular carcinoma
Jonathan H. Joachim, Kosha J. Mehta
British Journal of Cancer (2022) Vol. 127, Iss. 2, pp. 185-192
Open Access | Times Cited: 34

Showing 1-25 of 34 citing articles:

Non-alcoholic Fatty Liver Disease (NAFLD), Type 2 Diabetes, and Non-viral Hepatocarcinoma: Pathophysiological Mechanisms and New Therapeutic Strategies
Erica Vetrano, Luca Rinaldi, Andrea Mormone, et al.
Biomedicines (2023) Vol. 11, Iss. 2, pp. 468-468
Open Access | Times Cited: 47
Ferroptosis: a new hunter of hepatocellular carcinoma
Yulang Jiang, Yongxin Yu, Ziyang Pan, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 22
Managing the Dual Nature of Iron to Preserve Health
Laura Silvestri, Mariateresa Pettinato, Valeria Furiosi, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3995-3995
Open Access | Times Cited: 23
Targeting the regulation of iron homeostasis as a potential therapeutic strategy for nonalcoholic fatty liver disease
Yutong Sui, Xue Geng, Ziwei Wang, et al.
Metabolism (2024) Vol. 157, pp. 155953-155953
Closed Access | Times Cited: 16
Iron as a therapeutic target in chronic liver disease
Elias Kouroumalis, Ioannis Tsomidis, Argyro Voumvouraki
World Journal of Gastroenterology (2023) Vol. 29, Iss. 4, pp. 616-655
Open Access | Times Cited: 18
Protective Effects and Mechanism of Polysaccharides from Edible Medicinal Plants in Alcoholic Liver Injury: A Review
Zhuo-Wen Su, Tingyu Yan, Jing Feng, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 22, pp. 16530-16530
Open Access | Times Cited: 14
Prognostic MRI features to predict postresection survivals for very early to intermediate stage hepatocellular carcinoma
Hanyu Jiang, Yun Qin, Hong Wei, et al.
European Radiology (2023) Vol. 34, Iss. 5, pp. 3163-3182
Open Access | Times Cited: 11
Ferritin as an Effective Prognostic Factor and Potential Cancer Biomarker
Katarzyna Szymulewska-Konopko, Joanna Reszeć-Giełażyn, Mathias Maleczek
Current Issues in Molecular Biology (2025) Vol. 47, Iss. 1, pp. 60-60
Open Access
Diminishing Hepcidin via Reducing IL-6/STAT3 Pathway by Utilizing Ferulic Acid: An In Vitro Study
Ola M. Al-Sanabra, Luay Abu-Qatouseh, Mohammad I. Ahmad, et al.
Biomedicines (2025) Vol. 13, Iss. 4, pp. 923-923
Open Access
Diagnostic Significance of Serum Ferritin and Hepcidin as Complementary Biomarkers for Prostate Disease: A Prospective Case–Control Study in a Mission Hospital, Ghana
Samuel Kwasi Appiah, B Boateng, Charles Nkansah, et al.
Health Science Reports (2025) Vol. 8, Iss. 4
Open Access
Accurate quantification of cell-free Ceruloplasmin mRNA as a biomarker for early detection of hepatocellular carcinoma
Minh Ngo, Trang T. Dao, Trang Hoang, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
A novel cholesterol metabolism-related ferroptosis pathway in hepatocellular carcinoma
Weiwei Fang, Jianyong Liu, Fanguo Zhang, et al.
Discover Oncology (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 3
Iron and iron-related proteins in alcohol consumers: cellular and clinical aspects
Kevin Ferrao, Najma Ali, Kosha J. Mehta
Journal of Molecular Medicine (2022) Vol. 100, Iss. 12, pp. 1673-1689
Open Access | Times Cited: 14
Comprehensive Profiling and Therapeutic Insights into Differentially Expressed Genes in Hepatocellular Carcinoma
Wesley Ladeira Caputo, Milena Cremer de Souza, Caroline R. Basso, et al.
Cancers (2023) Vol. 15, Iss. 23, pp. 5653-5653
Open Access | Times Cited: 8
Distinctive modulation of hepcidin in cancer and its therapeutic relevance
Feng Lin, Alex Tuffour, Guijie Hao, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 7
Hepcidin Upregulation in Colorectal Cancer Associates with Accumulation of Regulatory Macrophages and Epithelial–Mesenchymal Transition and Correlates with Progression of the Disease
Antonio Di Grazia, Davide Di Fusco, Eleonora Franzè, et al.
Cancers (2022) Vol. 14, Iss. 21, pp. 5294-5294
Open Access | Times Cited: 11
Early assessment of chemotherapeutic response in hepatocellular carcinoma based on serum surface-enhanced Raman spectroscopy
Haiwei Li, Songqi Zhang, Ruochen Zhu, et al.
Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy (2022) Vol. 278, pp. 121314-121314
Closed Access | Times Cited: 10
Exploration of novel clusters and prognostic value of immune‑related signatures and identify HAMP as hub gene in colorectal cancer
Hongyuan Wu, Heling Dong, Shaofang Ren, et al.
Oncology Letters (2023) Vol. 26, Iss. 2
Open Access | Times Cited: 4
Iron Depletion in Systemic and Muscle Compartments Defines a Specific Phenotype of Severe COPD in Female and Male Patients: Implications in Exercise Tolerance
María Pérez-Peiró, Mariela Alvarado, Clara Martín‐Ontiyuelo, et al.
Nutrients (2022) Vol. 14, Iss. 19, pp. 3929-3929
Open Access | Times Cited: 7
Interplay between gut microbiota and the master iron regulator, hepcidin, in the pathogenesis of liver fibrosis
Sara Ahmadi Badi, Ahmad Bereimipour, Pejman Rohani, et al.
Pathogens and Disease (2024) Vol. 82
Open Access | Times Cited: 1
HAMP predicts a pivotal role in modulating the malignant behaviors of non-small cell lung cancer cells
Zhifeng Li, Jinglei Liu, Ping Wang, et al.
Aging (2024) Vol. 16, Iss. 10, pp. 8524-8540
Open Access | Times Cited: 1
Circulating Hepcidin Levels Are an Independent Predictor of Survival in Microsatellite Stable Metastatic Colorectal Cancer Patient Candidates for Standard First-Line Treatment
Vincenzo Formica, Antonio Di Grazia, Maria Vittoria Bonomo, et al.
Cancers (2024) Vol. 16, Iss. 23, pp. 3977-3977
Open Access | Times Cited: 1
Insights into Hepatocellular Carcinoma in Patients with Thalassemia: From Pathophysiology to Novel Therapies
Pei‐Chin Lin, Wan‐Yi Hsu, Po‐Yi Lee, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 16, pp. 12654-12654
Open Access | Times Cited: 3
Hepcidin is upregulated and is a potential therapeutic target associated with immunity in glioma
Tianyu Dong, Bo Zhang, Runjiao Zhang, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 5
Insights into Hepatocellular Carcinoma in Patients with Thalassemia: From Pathophysiology to Novel Therapies
Pei‐Chin Lin, Wan‐Yi Hsu, Po‐Yi Lee, et al.
(2023)
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top